source
- Lonza looks to ride ADC wave with upcoming factory, workforce expansionBASEL, Switzerland — Lonza said it wants to own the commercial market for antibody-drug conjugates, with a new manufacturing site set to come online next year and plans to increase its headcount. T…Endpoints · 2mo ago↗ source
- FDA Accepts sNDA for Taletrectinib in ROS1+ NSCLCAn sNDA with updated data for taletrectinib was accepted by the FDA for TKI-naive and pretreated advanced ROS1+ NSCLConclive · 2mo ago↗ source
- Cases and Conversations™: Next-Generation Pathology Advances and Considerations for Precision Care in Non–Small Cell Lung Canceronclive · 2mo ago↗ source